Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Allogeneic transplant recipients are at high risk of developing secondary malignancies as a late complication of therapy. We report a case of essential thrombocythemia occurring 8 years following bone marrow transplantation (BMT) for chronic myelogenous leukemia.